Langabeer, S.E., K. Haslam, M. Crampe, B. MacDonagh, and J. McHugh. “Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated With Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient With Chronic Myeloid Leukemia”. Experimental Oncology 41, no. 1 (June 8, 2023): 82–83. Accessed May 19, 2025. https://exp-oncology.com.ua/index.php/Exp/article/view/2019-1-1.